HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma clearance of lovastatin versus chinese red yeast rice in healthy volunteers.

AbstractOBJECTIVES:
It is now accepted that inhibition of cholesterol biosynthesis is effective in the primary and secondary prevention of heart disease. However, the perceived side-effects on muscle and liver reduce the general acceptance of statin drug therapy as well as compliance over the long term, which is necessary for prevention efforts to be successful. Chinese red yeast rice (CRYR) is a supplement containing lovastatin (monacolin K), eight other monacolins, pigments, tannins, and other phytochemicals. The authors previously reported on a double- blind placebo-controlled trial of CRYR supplement in 80 individuals demonstrating a significant decrease in cholesterol levels from 250 mg/dL to 210 mg/dL over 8 weeks independent of diet. The current study compared the pharmacokinetics of CRYR with lovastatin at the same bioeffective dose for lowering cholesterol.
METHODS:
Eleven (11) healthy volunteers were randomized to a crossover study taking 2400 mg CRYR or 20 mg of lovastatin.
RESULTS:
The Cmax and area under the curve (AUC) of lovastatin were 22.42 ng/mL, and 80.47 higher than CRYR (p = 0.001 and 0.002, respectively). The Cmax for lovastatin hydroxy-acid was 36.63 ng/mL higher than the Cmax of CRYR hydroxy-acid (p = 0.001). The AUC of lovastatin hydroxy-acid was 258.5 greater than that of CRYR (p = 0.001).
CONCLUSIONS:
The results suggested that the effect of CRYR on the cholesterol concentration might be caused by the additive and/or synergistic effects of monacolin K with other monacolins and substances in CRYR. It may lead to the ultimate development of a botanical supplement based on CRYR.
AuthorsZhaoping Li, Navindra P Seeram, Rupo Lee, Gail Thames, Chayo Minutti, He-Jing Wang, David Heber
JournalJournal of alternative and complementary medicine (New York, N.Y.) (J Altern Complement Med) Vol. 11 Issue 6 Pg. 1031-8 (Dec 2005) ISSN: 1075-5535 [Print] United States
PMID16398595 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Chemical References
  • Anticholesteremic Agents
  • Biological Products
  • red yeast rice
  • Cholesterol
  • Lovastatin
Topics
  • Adult
  • Anticholesteremic Agents (administration & dosage, blood, pharmacokinetics)
  • Area Under Curve
  • Biological Products (administration & dosage, blood, pharmacokinetics)
  • Cholesterol (blood)
  • Chromatography, High Pressure Liquid
  • Cross-Over Studies
  • Female
  • Humans
  • Lovastatin (administration & dosage, blood, pharmacokinetics)
  • Male
  • Middle Aged
  • Plasma (metabolism)
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: